KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2016 - 2023)

Historic Interest Coverage Ratio for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Q2 2023 value amounting to 19.33.

  • Supernus Pharmaceuticals' Interest Coverage Ratio fell 40830.9% to 19.33 in Q2 2023 from the same period last year, while for Mar 2024 it was 14.94, marking a year-over-year decrease of 30091.21%. This contributed to the annual value of 2.18 for FY2023, which is 13344.29% down from last year.
  • As of Q2 2023, Supernus Pharmaceuticals' Interest Coverage Ratio stood at 19.33, which was down 40830.9% from 3.44 recorded in Q1 2023.
  • In the past 5 years, Supernus Pharmaceuticals' Interest Coverage Ratio registered a high of 21.54 during Q4 2022, and its lowest value of 19.33 during Q2 2023.
  • For the 5-year period, Supernus Pharmaceuticals' Interest Coverage Ratio averaged around 4.58, with its median value being 5.87 (2021).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first surged by 199602.38% in 2022, then plummeted by 40830.9% in 2023.
  • Supernus Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 7.07 in 2019, then decreased by 0.17% to 7.05 in 2020, then plummeted by 85.43% to 1.03 in 2021, then soared by 1996.02% to 21.54 in 2022, then tumbled by 189.73% to 19.33 in 2023.
  • Its last three reported values are 19.33 in Q2 2023, 3.44 for Q1 2023, and 21.54 during Q4 2022.